Table S5 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer

Q: What type of study is this?

This is a Quantitative Study study.

Chi Mai Nguyen; Paul G. Yeh; Mai P. Nguyen; Travis S. Johnson; Hean Koo; Victoria L. Champion; Todd C. Skaar; David R. Lairson; Patrick O. Monahan; Thomas F. Imperiale; Hongmei Nan

doi:10.1158/2767-9764.30399523

October 20, 2025Open Access

Table S5 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer

View Full Paper

Ask AI

Bookmark

Share

Key Points

Prescription costs for metastatic colorectal cancer significantly exceed those for nonmetastatic cases, highlighting financial burdens.
Utilization of prescription cancer drugs and antibiotics illustrates differing treatment approaches between cancer stages.
Data sourced from the American Hospital Formular Service provides a comprehensive insight into cancer treatment costs.
Implications suggest that understanding treatment costs could enhance patient management strategies in colorectal cancer care.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Analysis reveals medical and prescription costs for metastatic colorectal cancer versus nonmetastatic cases, indicating significant treatment differences.

Abstract

Prescription cancer drugs, opiate and antibiotics identified by American Hospital Formular Service Pharmacologic-Therapeutic Classification

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nguyen et al. (2025) studied this question.

synapsesocial.com/papers/68f83319d24b29c9694819c1 https://doi.org/10.1158/2767-9764.30399523

View Full Paper

Ask AI

Bookmark

Share

Table S5 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Table S5 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading